Skip to content
Disclosery

EXANE DERIVATIVES: RVTY position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on RVTY, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 23 RVTY shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 23 shares
    Change vs previous 13F -722 shares

    <0.01% of the 13F portfolio, value $3,270.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 745 shares
    Change vs previous 13F -190 shares

    0.04% of the 13F portfolio, value $129,965.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 935 shares
    Change vs previous 13F -279 shares

    0.05% of the 13F portfolio, value $187,984.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,214 shares
    Change vs previous 13F -200 shares

    0.05% of the 13F portfolio, value $210,367.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,414 shares
    Change vs previous 13F -454 shares

    0.05% of the 13F portfolio, value $216,549.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,868 shares
    Change vs previous 13F -787 shares

    0.07% of the 13F portfolio, value $239,635.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,655 shares
    Change vs previous 13F not available

    0.12% of the 13F portfolio, value $380,975.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).